Business
A Vaccine Against a Widespread Common Cold Type Just Passed Promising Clinical Trials – ScienceAlert
A vaccine designed to prevent one of the most widespread common cold types has just delivered promising results in the latest set of clinical trials, and the developers now think it could actually reach the market in just a few years.
A vaccine designed to prevent one of the most widespread common cold types has just delivered promising results in the latest set of clinical trials, and the developers now think it could actually reach the market in just a few years.
The cold, known as respiratory syncytial virus (RSV), is so common, more than 90 percent of kids contract it by the age of two. In fact, this dangerous and sometimes deadly infection is the leading cause of serious lower respiratory diseases in children worldwide…
-
General19 hours agoGerman backpacker Carolina Wilga found alive in WA’s outback
-
Noosa News22 hours agoAustralian NFL player Laki Tasi comes home to convince kids to switch codes
-
Business21 hours agoHow $1,000 a month in this ASX ETF could turn into $500,000
-
Noosa News21 hours agoInside the final hours before Australian lawyer Christopher Saines died in Thai massage parlour